{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:00:51Z","timestamp":1792670451368,"version":"4.5.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13318-019-00552-0","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T02:02:30Z","timestamp":1555898550000},"page":"591-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children"],"prefix":"10.1007","volume":"44","author":[{"given":"James C.","family":"Thigpen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Odle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-3756","authenticated-orcid":false,"given":"Sam","family":"Harirforoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"issue":"5","key":"552_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/bja\/aen248","volume":"101","author":"KJ Anand","year":"2008","unstructured":"Anand KJ, Anderson BJ, Holford NH, Hall RW, Young T, Shephard B, et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Br J Anaesth. 2008;101(5):680\u20139. https:\/\/doi.org\/10.1093\/bja\/aen248 .","journal-title":"Br J Anaesth"},{"issue":"3","key":"552_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/mop.0000000000000347","volume":"28","author":"S Ruest","year":"2016","unstructured":"Ruest S, Anderson A. Management of acute pediatric pain in the emergency department. Curr Opin Pediatr. 2016;28(3):298\u2013304. https:\/\/doi.org\/10.1097\/mop.0000000000000347 .","journal-title":"Curr Opin Pediatr"},{"issue":"349","key":"552_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"12","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology\u2212drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;12(349):1157\u201367.","journal-title":"N Engl J Med"},{"issue":"1","key":"552_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpeds.2007.07.005","volume":"152","author":"M Hewitt","year":"2008","unstructured":"Hewitt M, Goldman A, Collins GS, Childs M, Hain R. Opioid use in palliative care of children and young people with cancer. J Pediatr. 2008;152(1):39\u201344. https:\/\/doi.org\/10.1016\/j.jpeds.2007.07.005 .","journal-title":"J Pediatr"},{"issue":"10","key":"552_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2217\/pgs.14.99","volume":"15","author":"R Venkatasubramanian","year":"2014","unstructured":"Venkatasubramanian R, Fukuda T, Niu J, Mizuno T, Chidambaran V, Vinks AA, et al. ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children. Pharmacogenomics. 2014;15(10):1297\u2013309. https:\/\/doi.org\/10.2217\/pgs.14.99 .","journal-title":"Pharmacogenomics"},{"issue":"8","key":"552_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.2174\/1570159X15666170504095823","volume":"15","author":"C Chaves","year":"2017","unstructured":"Chaves C, Remiao F, Cisternino S, Decleves X. Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain. Curr Neuropharmacol. 2017;15(8):1156\u201373. https:\/\/doi.org\/10.2174\/1570159X15666170504095823 .","journal-title":"Curr Neuropharmacol"},{"key":"552_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040192","author":"J Yang","year":"2018","unstructured":"Yang J, Reilly BG, Davis TP, Ronaldson PT. Modulation of opioid transport at the blood-brain barrier by altered ATP-binding cassette (ABC) transporter expression and activity. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10040192 .","journal-title":"Pharmaceutics"},{"issue":"3","key":"552_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/cpt.176","volume":"98","author":"KL Brouwer","year":"2015","unstructured":"Brouwer KL, Aleksunes LM, Brandys B, Giacoia GP, Knipp G, Lukacova V, et al. Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working group. Clin Pharmacol Ther. 2015;98(3):266\u201387. https:\/\/doi.org\/10.1002\/cpt.176 .","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"552_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/clpt.1988.127","volume":"44","author":"KT Olkkola","year":"1988","unstructured":"Olkkola KT, Maunuksela EL, Korpela R, Rosenberg PH. Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther. 1988;44(2):128\u201336.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"552_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1046\/j.1460-9592.1997.d01-30.x","volume":"7","author":"T Kart","year":"1997","unstructured":"Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 1\u2013pharmacokinetics. Paediatr Anaesth. 1997;7(1):5\u201311.","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"552_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0304-3959(00)00313-4","volume":"88","author":"AM Lynn","year":"2000","unstructured":"Lynn AM, Nespeca MK, Bratton SL, Shen DD. Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions. Pain. 2000;88(1):89\u201395.","journal-title":"Pain"},{"issue":"6","key":"552_CR12","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1542\/peds.2004-1425","volume":"115","author":"R Carbajal","year":"2005","unstructured":"Carbajal R, Lenclen R, Jugie M, Paupe A, Barton BA, Anand KJ. Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Pediatrics. 2005;115(6):1494\u2013500. https:\/\/doi.org\/10.1542\/peds.2004-1425 .","journal-title":"Pediatrics"},{"issue":"1","key":"552_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5055\/jom.2007.0039","volume":"3","author":"K Allegaert","year":"2007","unstructured":"Allegaert K, Simons SH, Vanhole C, Tibboel D. Developmental pharmacokinetics of opioids in neonates. J Opioid Manag. 2007;3(1):59\u201364.","journal-title":"J Opioid Manag"},{"key":"552_CR14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3479","author":"RS Gammal","year":"2016","unstructured":"Gammal RS, Crews KR, Haidar CE, Hoffman JM, Baker DK, Barker PJ, et al. Pharmacogenetics for safe codeine use in sickle cell disease. Pediatrics. 2016. https:\/\/doi.org\/10.1542\/peds.2015-3479 .","journal-title":"Pediatrics"},{"issue":"14","key":"552_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1056\/NEJMra012626","volume":"347","author":"CB Berde","year":"2002","unstructured":"Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med. 2002;347(14):1094\u2013103. https:\/\/doi.org\/10.1056\/NEJMra012626 .","journal-title":"N Engl J Med"},{"issue":"4","key":"552_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1213\/00000539-199310000-00007","volume":"77","author":"AM Lynn","year":"1993","unstructured":"Lynn AM, Nespeca MK, Opheim KE, Slattery JT. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg. 1993;77(4):695\u2013701.","journal-title":"Anesth Analg"},{"issue":"4","key":"552_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/bja\/aen025","volume":"100","author":"S Eschertzhuber","year":"2008","unstructured":"Eschertzhuber S, Hohlrieder M, Keller C, Oswald E, Kuehbacher G, Innerhofer P. Comparison of high- and low-dose intrathecal morphine for spinal fusion in children. Br J Anaesth. 2008;100(4):538\u201343. https:\/\/doi.org\/10.1093\/bja\/aen025 .","journal-title":"Br J Anaesth"},{"issue":"4","key":"552_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.siny.2006.02.008","volume":"11","author":"SH Simons","year":"2006","unstructured":"Simons SH, Anand KJ. Pain control: opioid dosing, population kinetics and side-effects. Semin Fetal Neonatal Med. 2006;11(4):260\u20137. https:\/\/doi.org\/10.1016\/j.siny.2006.02.008 .","journal-title":"Semin Fetal Neonatal Med"},{"issue":"11","key":"552_CR19","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00134-003-1899-4","volume":"29","author":"NJ Bouwmeester","year":"2003","unstructured":"Bouwmeester NJ, Hop WC, van Dijk M, Anand KJ, van den Anker JN, Tibboel D. Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism. Intensive Care Med. 2003;29(11):2009\u201315. https:\/\/doi.org\/10.1007\/s00134-003-1899-4 .","journal-title":"Intensive Care Med"},{"key":"552_CR20","volume-title":"A practice of anesthesia for infants and children","author":"C Cote","year":"2009","unstructured":"Cote C, Lerman J, Todres ID. A practice of anesthesia for infants and children. 4th ed. Philadelphia: Saunders; 2009.","edition":"4"},{"issue":"8","key":"552_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jcph.696","volume":"56","author":"T Liu","year":"2016","unstructured":"Liu T, Lewis T, Gauda E, Gobburu J, Ivaturi V. Mechanistic population pharmacokinetics of morphine in neonates with abstinence syndrome after oral administration of diluted tincture of opium. J Clin Pharmacol. 2016;56(8):1009\u201318. https:\/\/doi.org\/10.1002\/jcph.696 .","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"552_CR22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s40262-015-0256-4","volume":"54","author":"N Velez de Mendizabal","year":"2015","unstructured":"Velez de Mendizabal N, Jimenez-Mendez R, Cooke E, Montgomery CJ, Dawes J, Rieder MJ, et al. A compartmental analysis for morphine and its metabolites in young children after a single oral dose. Clin Pharmacokinet. 2015;54(10):1083\u201390. https:\/\/doi.org\/10.1007\/s40262-015-0256-4 .","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"552_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/pan.13020","volume":"27","author":"JM Dawes","year":"2017","unstructured":"Dawes JM, Cooke EM, Hannam JA, Brand KA, Winton P, Jimenez-Mendez R, et al. Oral morphine dosing predictions based on single dose in healthy children undergoing surgery. Paediatr Anaesth. 2017;27(1):28\u201336. https:\/\/doi.org\/10.1111\/pan.13020 .","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"552_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-3476(99)70326-4","volume":"135","author":"A Hunt","year":"1999","unstructured":"Hunt A, Joel S, Dick G, Goldman A. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. J Pediatr. 1999;135(1):47\u201355.","journal-title":"J Pediatr"},{"issue":"4","key":"552_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1399-6576.1996.tb04467.x","volume":"40","author":"S Lundeberg","year":"1996","unstructured":"Lundeberg S, Beck O, Olsson GL, Boreus LO. Rectal administration of morphine in children. Pharmacokinetic evaluation after a single-dose. Acta Anaesthesiol Scand. 1996;40(4):445\u201351.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6829","key":"552_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/bmj.304.6829.766","volume":"304","author":"GK Gourlay","year":"1992","unstructured":"Gourlay GK, Boas RA. Fatal outcome with use of rectal morphine for postoperative pain control in an infant. BMJ. 1992;304(6829):766\u20137.","journal-title":"BMJ"},{"issue":"4","key":"552_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/00000542-199310000-00015","volume":"79","author":"DG Nichols","year":"1993","unstructured":"Nichols DG, Yaster M, Lynn AM, Helfaer MA, Deshpande JK, Manson PN, et al. Disposition and respiratory effects of intrathecal morphine in children. Anesthesiology. 1993;79(4):733\u20138.","journal-title":"Anesthesiology"},{"issue":"2","key":"552_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/bja\/56.2.137","volume":"56","author":"SE Jones","year":"1984","unstructured":"Jones SE, Beasley JM, Macfarlane DW, Davis JM, Hall-Davies G. Intrathecal morphine for postoperative pain relief in children. Br J Anaesth. 1984;56(2):137\u201340.","journal-title":"Br J Anaesth"},{"issue":"8","key":"552_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.6061\/clinics\/2016(08)11","volume":"71","author":"GM Pacifici","year":"2016","unstructured":"Pacifici GM. Metabolism and pharmacokinetics of morphine in neonates: a review. Clinics (Sao Paulo). 2016;71(8):474\u201380. https:\/\/doi.org\/10.6061\/clinics\/2016(08)11 .","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"552_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/J354v16n04_02","volume":"16","author":"RA Lugo","year":"2002","unstructured":"Lugo RA, Kern SE. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother. 2002;16(4):5\u201318.","journal-title":"J Pain Palliat Care Pharmacother."},{"issue":"5","key":"552_CR31","doi-asserted-by":"publisher","first-page":"e1343","DOI":"10.1542\/peds.2011-2538","volume":"129","author":"LE Kelly","year":"2012","unstructured":"Kelly LE, Rieder M, van den Anker J, Malkin B, Ross C, Neely MN, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics. 2012;129(5):e1343\u20137. https:\/\/doi.org\/10.1542\/peds.2011-2538 .","journal-title":"Pediatrics"},{"issue":"3","key":"552_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/archdischild-2014-307286","volume":"101","author":"P Andrzejowski","year":"2016","unstructured":"Andrzejowski P, Carroll W. Codeine in paediatrics: pharmacology, prescribing and controversies. Arch Dis Child Educ Pract Ed. 2016;101(3):148\u201351. https:\/\/doi.org\/10.1136\/archdischild-2014-307286 .","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"4","key":"552_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/clpt.1992.153","volume":"52","author":"ML Pokela","year":"1992","unstructured":"Pokela ML, Olkkola KT, Koivisto M, Ryh\u00e4nen P. Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther. 1992;52(4):342\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"552_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5863\/1551-6776-16.3.167","volume":"16","author":"ML Buck","year":"2011","unstructured":"Buck ML. Is meperidine the drug that just won\u2019t die? J Pediatr Pharmacol Ther. 2011;16(3):167\u20139. https:\/\/doi.org\/10.5863\/1551-6776-16.3.167 .","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"552_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2165\/00003088-197803050-00002","volume":"3","author":"LE Mather","year":"1978","unstructured":"Mather LE, Meffin PJ. Clinical pharmacokinetics of pethidine. Clin Pharmacokinet. 1978;3(5):352\u201368. https:\/\/doi.org\/10.2165\/00003088-197803050-00002 .","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"552_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0736-4679(95)02002-0","volume":"13","author":"RF Clark","year":"1995","unstructured":"Clark RF, Wei EM, Anderson PO. Meperidine: therapeutic use and toxicity. J Emerg Med. 1995;13(6):797\u2013802.","journal-title":"J Emerg Med"},{"issue":"5","key":"552_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.17796\/1053-4628-39.5.481","volume":"39","author":"M Lenahan","year":"2015","unstructured":"Lenahan M, Wells M, Scarbecz M. A retrospective study of 248 pediatric oral sedations utilizing the combination of meperidine and hydroxyzine for dental treatment. J Clin Pediatr Dent. 2015;39(5):481\u20137. https:\/\/doi.org\/10.17796\/1053-4628-39.5.481 .","journal-title":"J Clin Pediatr Dent"},{"issue":"4","key":"552_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0887-8994(96)00062-8","volume":"14","author":"RP Saneto","year":"1996","unstructured":"Saneto RP, Fitch JA, Cohen BH. Acute neurotoxicity of meperidine in an infant. Pediatr Neurol. 1996;14(4):339\u201341.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"552_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1046\/j.1460-9592.2000.0566d.x","volume":"10","author":"S Bari\u015f","year":"2000","unstructured":"Bari\u015f S, Karakaya D, Sarihasan B. A dose of 1\u00a0mg\u00b7kg\u22121 meperidine causes muscle rigidity in infants? Paediatr Anaesth. 2000;10(6):684.","journal-title":"Paediatr Anaesth"},{"issue":"5","key":"552_CR40","first-page":"337","volume":"9","author":"JV Kyff","year":"1990","unstructured":"Kyff JV, Rice TL. Meperidine-associated seizures in a child. Clin Pharm. 1990;9(5):337\u20138.","journal-title":"Clin Pharm"},{"issue":"3","key":"552_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1542\/peds.108.3.793","volume":"108","author":"Health AAoPCoPAoCaF, Task Force on Pain in Infants Ci, and Adolescents","year":"2001","unstructured":"Health AAoPCoPAoCaF, Task Force on Pain in Infants Ci, and Adolescents. The assessment and management of acute pain in infants, children, and adolescents. Pediatrics. 2001;108(3):793\u20137.","journal-title":"Pediatrics"},{"issue":"9","key":"552_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2165\/00003088-200443090-00004","volume":"43","author":"H Kokki","year":"2004","unstructured":"Kokki H, Rasanen I, Reinikainen M, Suhonen P, Vanamo K, Ojanper\u00e4 I. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin Pharmacokinet. 2004;43(9):613\u201322. https:\/\/doi.org\/10.2165\/00003088-200443090-00004 .","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"552_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2217\/pgs-2016-0183","volume":"18","author":"R Balyan","year":"2017","unstructured":"Balyan R, Mecoli M, Venkatasubramanian R, Chidambaran V, Kamos N, Clay S, et al. CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients. Pharmacogenomics. 2017;18(4):337\u201348. https:\/\/doi.org\/10.2217\/pgs-2016-0183 .","journal-title":"Pharmacogenomics"},{"issue":"1","key":"552_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2125.1994.tb04324.x","volume":"38","author":"KT Olkkola","year":"1994","unstructured":"Olkkola KT, Hamunen K, Sepp\u00e4l\u00e4 T, Maunuksela EL. Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children. Br J Clin Pharmacol. 1994;38(1):71\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"552_CR45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00007691-199212000-00008","volume":"14","author":"KP Leow","year":"1992","unstructured":"Leow KP, Smith MT, Watt JA, Williams BE, Cramond T. Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration. Ther Drug Monit. 1992;14(6):479\u201384.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"552_CR46","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2125.1991.tb03942.x","volume":"32","author":"R P\u00f6yhi\u00e4","year":"1991","unstructured":"P\u00f6yhi\u00e4 R, Olkkola KT, Sepp\u00e4l\u00e4 T, Kalso E. The pharmacokinetics of oxycodone after intravenous injection in adults. Br J Clin Pharmacol. 1991;32(4):516\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"552_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1399-6576.1997.tb04684.x","volume":"41","author":"A Takala","year":"1997","unstructured":"Takala A, Kaasalainen V, Seppala T, Kalso E, Olkkola KT. Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone. Acta Anaesthesiol Scand. 1997;41(2):309\u201312.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"552_CR48","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1460-9592.2005.01571.x","volume":"15","author":"ML Pokela","year":"2005","unstructured":"Pokela ML, Anttila E, Sepp\u00e4l\u00e4 T, Olkkola KT. Marked variation in oxycodone pharmacokinetics in infants. Paediatr Anaesth. 2005;15(7):560\u20135. https:\/\/doi.org\/10.1111\/j.1460-9592.2005.01571.x .","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"552_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00008571-199706000-00003","volume":"7","author":"RA McLellan","year":"1997","unstructured":"McLellan RA, Oscarson M, Seideg\u00e5rd J, Evans DA, Ingelman-Sundberg M. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics. 1997;7(3):187\u201391.","journal-title":"Pharmacogenetics"},{"issue":"1","key":"552_CR50","first-page":"441","volume":"278","author":"E Aklillu","year":"1996","unstructured":"Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther. 1996;278(1):441\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"552_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/01.jcp.0000085421.74359.60","volume":"23","author":"J Leon de","year":"2003","unstructured":"de Leon J, Dinsmore L, Wedlund P. Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers. J Clin Psychopharmacol. 2003;23(4):420\u20131. https:\/\/doi.org\/10.1097\/01.jcp.0000085421.74359.60 .","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"552_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/jcph.394","volume":"55","author":"W Liu","year":"2015","unstructured":"Liu W, Dutta S, Kearns G, Awni W, Neville KA. Pharmacokinetics of hydrocodone\/acetaminophen combination product in children ages 6\u201317 with moderate to moderately severe postoperative pain. J Clin Pharmacol. 2015;55(2):204\u201311. https:\/\/doi.org\/10.1002\/jcph.394 .","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"552_CR53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/AOG.0b013e31820ca504","volume":"117","author":"JB Sauberan","year":"2011","unstructured":"Sauberan JB, Anderson PO, Lane JR, Rafie S, Nguyen N, Rossi SS, et al. Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain. Obstet Gynecol. 2011;117(3):611\u20137. https:\/\/doi.org\/10.1097\/AOG.0b013e31820ca504 .","journal-title":"Obstet Gynecol"},{"issue":"7","key":"552_CR54","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1097\/MPH.0b013e31828e52d2","volume":"35","author":"MM Yee","year":"2013","unstructured":"Yee MM, Josephson C, Hill CE, Harrington R, Castillejo MI, Ramjit R, et al. Cytochrome P450 2D6 polymorphisms and predicted opioid metabolism in African American children with sickle cell disease. J Pediatr Hematol Oncol. 2013;35(7):e301\u20135. https:\/\/doi.org\/10.1097\/MPH.0b013e31828e52d2 .","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"552_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pedneo.2014.06.002","volume":"56","author":"GM Pacifici","year":"2015","unstructured":"Pacifici GM. Clinical pharmacology of fentanyl in preterm infants. A review. Pediatr Neonatol. 2015;56(3):143\u20138. https:\/\/doi.org\/10.1016\/j.pedneo.2014.06.002 .","journal-title":"Pediatr Neonatol"},{"issue":"7","key":"552_CR56","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/00003246-199307000-00012","volume":"21","author":"R Katz","year":"1993","unstructured":"Katz R, Kelly HW. Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med. 1993;21(7):995\u20131000.","journal-title":"Crit Care Med"},{"issue":"4","key":"552_CR57","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0022-3476(05)82419-9","volume":"119","author":"JH Arnold","year":"1991","unstructured":"Arnold JH, Truog RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr. 1991;119(4):639\u201343.","journal-title":"J Pediatr"},{"issue":"3","key":"552_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40272-017-0216-6","volume":"19","author":"JD Vaughns","year":"2017","unstructured":"Vaughns JD, Ziesenitz VC, Williams EF, Mushtaq A, Bachmann R, Skopp G, et al. Use of fentanyl in adolescents with clinically severe obesity undergoing bariatric surgery: a pilot study. Paediatr Drugs. 2017;19(3):251\u20137. https:\/\/doi.org\/10.1007\/s40272-017-0216-6 .","journal-title":"Paediatr Drugs"},{"issue":"2","key":"552_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00000542-199108000-00009","volume":"75","author":"JB Streisand","year":"1991","unstructured":"Streisand JB, Varvel JR, Stanski DR, Le Maire L, Ashburn MA, Hague BI, et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology. 1991;75(2):223\u20139.","journal-title":"Anesthesiology"},{"issue":"7","key":"552_CR60","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1046\/j.1460-9592.2002.00949.x","volume":"12","author":"M Wheeler","year":"2002","unstructured":"Wheeler M, Birmingham PK, Dsida RM, Wang Z, Cot\u00e9 CJ, Avram MJ. Uptake pharmacokinetics of the Fentanyl Oralet in children scheduled for central venous access removal: implications for the timing of initiating painful procedures. Paediatr Anaesth. 2002;12(7):594\u20139.","journal-title":"Paediatr Anaesth"},{"issue":"5","key":"552_CR61","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1213\/01.ane.0000132777.00967.a3","volume":"99","author":"M Wheeler","year":"2004","unstructured":"Wheeler M, Birmingham PK, Lugo RA, Heffner CL, Cot\u00e9 CJ. The pharmacokinetics of the intravenous formulation of fentanyl citrate administered orally in children undergoing general anesthesia. Anesth Analg. 2004;99(5):1347\u201351. https:\/\/doi.org\/10.1213\/01.ane.0000132777.00967.a3.","journal-title":"Anesth Analg"},{"issue":"3","key":"552_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1742-6723.2009.01183.x","volume":"21","author":"JS Furyk","year":"2009","unstructured":"Furyk JS, Grabowski WJ, Black LH. Nebulized fentanyl versus intravenous morphine in children with suspected limb fractures in the emergency department: a randomized controlled trial. Emerg Med Australas. 2009;21(3):203\u20139. https:\/\/doi.org\/10.1111\/j.1742-6723.2009.01183.x .","journal-title":"Emerg Med Australas"},{"issue":"1","key":"552_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/bja\/81.1.3","volume":"81","author":"JM Alexander-Williams","year":"1998","unstructured":"Alexander-Williams JM, Rowbotham DJ. Novel routes of opioid administration. Br J Anaesth. 1998;81(1):3\u20137.","journal-title":"Br J Anaesth"},{"issue":"10","key":"552_CR64","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1197\/j.aem.2007.06.036","volume":"14","author":"JR Miner","year":"2007","unstructured":"Miner JR, Kletti C, Herold M, Hubbard D, Biros MH. Randomized clinical trial of nebulized fentanyl citrate versus i.v. fentanyl citrate in children presenting to the emergency department with acute pain. Acad Emerg Med. 2007;14(10):895\u20138. https:\/\/doi.org\/10.1197\/j.aem.2007.06.036 .","journal-title":"Acad Emerg Med"},{"issue":"3","key":"552_CR65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jpain.2006.11.008","volume":"8","author":"B Zernikow","year":"2007","unstructured":"Zernikow B, Michel E, Anderson B. Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. J Pain. 2007;8(3):187\u2013207. https:\/\/doi.org\/10.1016\/j.jpain.2006.11.008 .","journal-title":"J Pain"},{"issue":"3 Suppl","key":"552_CR66","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/0885-3924(92)90049-N","volume":"7","author":"SK Gupta","year":"1992","unstructured":"Gupta SK, Southam M, Gale R, Hwang SS. System functionality and physicochemical model of fentanyl transdermal system. J Pain Symptom Manag. 1992;7(3 Suppl):S17\u201326.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"552_CR67","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/00043426-199611000-00007","volume":"18","author":"ML Christensen","year":"1996","unstructured":"Christensen ML, Wang WC, Harris S, Eades SK, Wilimas JA. Transdermal fentanyl administration in children and adolescents with sickle cell pain crisis. J Pediatr Hematol Oncol. 1996;18(4):372\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"552_CR68","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1046\/j.1365-2044.2000.01615-3.x","volume":"55","author":"O Paut","year":"2000","unstructured":"Paut O, Camboulives J, Viard L, Lemoing JP, Levron JC. Pharmacokinetics of transdermal fentanyl in the peri-operative period in young children. Anaesthesia. 2000;55(12):1202\u20137.","journal-title":"Anaesthesia"},{"issue":"12","key":"552_CR69","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1002\/cncr.21497","volume":"104","author":"JC Finkel","year":"2005","unstructured":"Finkel JC, Finley A, Greco C, Weisman SJ, Zeltzer L. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study. Cancer. 2005;104(12):2847\u201357. https:\/\/doi.org\/10.1002\/cncr.21497 .","journal-title":"Cancer"},{"issue":"4","key":"552_CR70","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/00000542-200110000-00006","volume":"95","author":"KJ Anand","year":"2001","unstructured":"Anand KJ, Maze M. Fetuses, fentanyl, and the stress response: signals from the beginnings of pain? Anesthesiology. 2001;95(4):823\u20135.","journal-title":"Anesthesiology"},{"issue":"4","key":"552_CR71","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/MOP.0b013e328355b2c5","volume":"24","author":"RE Cramton","year":"2012","unstructured":"Cramton RE, Gruchala NE. Managing procedural pain in pediatric patients. Curr Opin Pediatr. 2012;24(4):530\u20138. https:\/\/doi.org\/10.1097\/MOP.0b013e328355b2c5 .","journal-title":"Curr Opin Pediatr"},{"issue":"5 Pt 2","key":"552_CR72","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1542\/peds.86.5.826","volume":"86","author":"LK Zeltzer","year":"1990","unstructured":"Zeltzer LK, Altman A, Cohen D, LeBaron S, Munuksela EL, Schechter NL. American Academy of Pediatrics Report of the Subcommittee on the management of pain associated with procedures in children with cancer. Pediatrics. 1990;86(5 Pt 2):826\u201331.","journal-title":"Pediatrics"},{"issue":"3","key":"552_CR73","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.annemergmed.2006.06.016","volume":"49","author":"M Borland","year":"2007","unstructured":"Borland M, Jacobs I, King B, O\u2019Brien D. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007;49(3):335\u201340. https:\/\/doi.org\/10.1016\/j.annemergmed.2006.06.016 .","journal-title":"Ann Emerg Med"},{"issue":"4","key":"552_CR74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1742-6723.2009.01207.x","volume":"21","author":"D Herd","year":"2009","unstructured":"Herd D, Borland M. Intranasal fentanyl paediatric clinical practice guidelines. Emerg Med Australas. 2009;21(4):335. https:\/\/doi.org\/10.1111\/j.1742-6723.2009.01207.x .","journal-title":"Emerg Med Australas"},{"issue":"12","key":"552_CR75","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/1097-0142(20011215)92:12<3056::AID-CNCR10166>3.0.CO;2-H","volume":"92","author":"CA Kornick","year":"2001","unstructured":"Kornick CA, Santiago-Palma J, Khojainova N, Primavera LH, Payne R, Manfredi PL. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl. Cancer. 2001;92(12):3056\u201361.","journal-title":"Cancer"},{"issue":"4 Spec No","key":"552_CR76","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/adc.65.4_Spec_No.349","volume":"65","author":"N Marlow","year":"1990","unstructured":"Marlow N, Weindling AM, Van Peer A, Heykants J. Alfentanil pharmacokinetics in preterm infants. Arch Dis Child. 1990;65(4 Spec No):349\u201351.","journal-title":"Arch Dis Child"},{"issue":"11","key":"552_CR77","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/bja\/59.11.1437","volume":"59","author":"P Roure","year":"1987","unstructured":"Roure P, Jean N, Leclerc AC, Cabanel N, Levron JC, Duvaldestin P. Pharmacokinetics of alfentanil in children undergoing surgery. Br J Anaesth. 1987;59(11):1437\u201340.","journal-title":"Br J Anaesth"},{"issue":"3","key":"552_CR78","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1460-9592.2010.03411.x","volume":"21","author":"S Lundeberg","year":"2011","unstructured":"Lundeberg S, Roelofse JA. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Paediatr Anaesth. 2011;21(3):274\u20139. https:\/\/doi.org\/10.1111\/j.1460-9592.2010.03411.x .","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"552_CR79","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1213\/00000539-198803000-00010","volume":"67","author":"PJ Davis","year":"1988","unstructured":"Davis PJ, Stiller RL, Cook DR, Brandom BW, Davin-Robinson KA. Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. Anesth Analg. 1988;67(3):268\u201371.","journal-title":"Anesth Analg"},{"issue":"11","key":"552_CR80","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1213\/00000539-198711000-00001","volume":"66","author":"WJ Greeley","year":"1987","unstructured":"Greeley WJ, de Bruijn NP, Davis DP. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg. 1987;66(11):1067\u201372.","journal-title":"Anesth Analg"},{"issue":"1","key":"552_CR81","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jcph.577","volume":"56","author":"A Bartkowska-\u015aniatkowska","year":"2016","unstructured":"Bartkowska-\u015aniatkowska A, Bienert A, Wiczling P, Rosada-Kurasi\u0144ska J, Zieli\u0144ska M, Warzybok J, et al. Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients. J Clin Pharmacol. 2016;56(1):109\u201315. https:\/\/doi.org\/10.1002\/jcph.577 .","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"552_CR82","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF03037044","volume":"40","author":"G Haynes","year":"1993","unstructured":"Haynes G, Brahen NH, Hill HF. Plasma sufentanil concentration after intranasal administration to paediatric outpatients. Can J Anaesth. 1993;40(3):286. https:\/\/doi.org\/10.1007\/BF03037044 .","journal-title":"Can J Anaesth"},{"issue":"3","key":"552_CR83","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2044.2008.05731.x","volume":"64","author":"DF Marsh","year":"2009","unstructured":"Marsh DF, Hodkinson B. Remifentanil in paediatric anaesthetic practice. Anaesthesia. 2009;64(3):301\u20138. https:\/\/doi.org\/10.1111\/j.1365-2044.2008.05731.x .","journal-title":"Anaesthesia"},{"issue":"6","key":"552_CR84","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/00000539-200112000-00008","volume":"93","author":"AK Ross","year":"2001","unstructured":"Ross AK, Davis PJ, Dear Gd GL, Ginsberg B, McGowan FX, Stiller RD, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg. 2001;93(6):1393\u2013401.","journal-title":"Anesth Analg"},{"issue":"1","key":"552_CR85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1460-9592.2009.03174.x","volume":"20","author":"JF Standing","year":"2010","unstructured":"Standing JF, Hammer GB, Sam WJ, Drover DR. Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty. Paediatr Anaesth. 2010;20(1):7\u201318. https:\/\/doi.org\/10.1111\/j.1460-9592.2009.03174.x .","journal-title":"Paediatr Anaesth"},{"issue":"4","key":"552_CR86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13\u201324.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"2","key":"552_CR87","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1365-2125.2004.02116.x","volume":"58","author":"O Dale","year":"2004","unstructured":"Dale O, Sheffels P, Kharasch ED. Bioavailabilities of rectal and oral methadone in healthy subjects. Br J Clin Pharmacol. 2004;58(2):156\u201362. https:\/\/doi.org\/10.1111\/j.1365-2125.2004.02116.x .","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"552_CR88","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/pan.12385","volume":"24","author":"RM Ward","year":"2014","unstructured":"Ward RM, Drover DR, Hammer GB, Stemland CJ, Kern S, Tristani-Firouzi M, et al. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children. Paediatr Anaesth. 2014;24(6):591\u2013601. https:\/\/doi.org\/10.1111\/pan.12385 .","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"552_CR89","doi-asserted-by":"publisher","first-page":"121420.e3","DOI":"10.1016\/j.jpeds.2015.08.032","volume":"167","author":"JR Wiles","year":"2015","unstructured":"Wiles JR, Isemann B, Mizuno T, Tabangin ME, Ward LP, Akinbi H, et al. Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study. J Pediatr. 2015;167(6):121420.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2015.08.032 .","journal-title":"J Pediatr"},{"issue":"3","key":"552_CR90","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","volume":"134","author":"S Grassin-Delyle","year":"2012","unstructured":"Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc LJ, et al. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther. 2012;134(3):366\u201379. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.003 .","journal-title":"Pharmacol Ther"},{"issue":"14","key":"552_CR91","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"CB Eap","year":"2002","unstructured":"Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002;41(14):1153\u201393. https:\/\/doi.org\/10.2165\/00003088-200241140-00003 .","journal-title":"Clin Pharmacokinet"},{"issue":"1 Pt 1","key":"552_CR92","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0022-3476(05)81054-6","volume":"119","author":"CB Berde","year":"1991","unstructured":"Berde CB, Beyer JE, Bournaki MC, Levin CR, Sethna NF. Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. J Pediatr. 1991;119(1 Pt 1):136\u201341.","journal-title":"J Pediatr"},{"issue":"6","key":"552_CR93","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/ALN.0b013e318238fec5","volume":"115","author":"A Sharma","year":"2011","unstructured":"Sharma A, Tallchief D, Blood J, Kim T, London A, Kharasch ED. Perioperative pharmacokinetics of methadone in adolescents. Anesthesiology. 2011;115(6):1153\u201361. https:\/\/doi.org\/10.1097\/ALN.0b013e318238fec5 .","journal-title":"Anesthesiology"},{"issue":"4","key":"552_CR94","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/jp.2014.194","volume":"35","author":"MS Brown","year":"2015","unstructured":"Brown MS, Hayes MJ, Thornton LM. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol. 2015;35(4):278\u201383. https:\/\/doi.org\/10.1038\/jp.2014.194 .","journal-title":"J Perinatol"},{"issue":"2","key":"552_CR95","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00003246-199402000-00027","volume":"22","author":"KJ Anand","year":"1994","unstructured":"Anand KJ, Arnold JH. Opioid tolerance and dependence in infants and children. Crit Care Med. 1994;22(2):334\u201342.","journal-title":"Crit Care Med"},{"issue":"1","key":"552_CR96","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1542\/peds.2013-3398","volume":"133","author":"J Galinkin","year":"2014","unstructured":"Galinkin J, Koh JL, Drugs Co, Medicine SOAaP, Pediatrics AAo. Recognition and management of iatrogenically induced opioid dependence and withdrawal in children. Pediatrics. 2014;133(1):152\u20135. https:\/\/doi.org\/10.1542\/peds.2013-3398 .","journal-title":"Pediatrics"},{"issue":"7","key":"552_CR97","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","volume":"44","author":"A Elkader","year":"2005","unstructured":"Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet. 2005;44(7):661\u201380. https:\/\/doi.org\/10.2165\/00003088-200544070-00001 .","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"552_CR98","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2125.1993.tb04220.x","volume":"36","author":"DA Barrett","year":"1993","unstructured":"Barrett DA, Simpson J, Rutter N, Kurihara-Bergstrom T, Shaw PN, Davis SS. The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates. Br J Clin Pharmacol. 1993;36(3):215\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"552_CR99","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/phar.1610","volume":"35","author":"CM Ng","year":"2015","unstructured":"Ng CM, Dombrowsky E, Lin H, Erlich ME, Moody DE, Barrett JS, et al. Population pharmacokinetic model of sublingual buprenorphine in neonatal abstinence syndrome. Pharmacotherapy. 2015;35(7):670\u201380. https:\/\/doi.org\/10.1002\/phar.1610 .","journal-title":"Pharmacotherapy"},{"issue":"6","key":"552_CR100","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/cpt.1064","volume":"103","author":"JN Moore","year":"2018","unstructured":"Moore JN, Gastonguay MR, Ng CM, Adeniyi-Jones SC, Moody DE, Fang WB, et al. The pharmacokinetics and pharmacodynamics of buprenorphine in neonatal abstinence syndrome. Clin Pharmacol Ther. 2018;103(6):1029\u201337. https:\/\/doi.org\/10.1002\/cpt.1064 .","journal-title":"Clin Pharmacol Ther"},{"key":"552_CR101","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cca.2013.11.015","volume":"429","author":"ME Stauble","year":"2014","unstructured":"Stauble ME, Moore AW, Langman LJ, Boswell MV, Baumgartner R, McGee S, et al. Hydrocodone in postoperative personalized pain management: pro-drug or drug? Clin Chim Acta. 2014;429:26\u20139. https:\/\/doi.org\/10.1016\/j.cca.2013.11.015 .","journal-title":"Clin Chim Acta"},{"issue":"4","key":"552_CR102","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1360-0443.1998.93454910.x","volume":"93","author":"JJ Kuhlman Jr","year":"1998","unstructured":"Kuhlman JJ Jr, Levine B, Johnson RE, Fudala PJ, Cone EJ. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction. 1998;93(4):549\u201359.","journal-title":"Addiction"},{"issue":"10","key":"552_CR103","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMc1709121","volume":"377","author":"WK Kraft","year":"2017","unstructured":"Kraft WK, Adeniyi-Jones SC, Ehrlich ME. Buprenorphine for the neonatal abstinence syndrome. N Engl J Med. 2017;377(10):997\u20138. https:\/\/doi.org\/10.1056\/NEJMc1709121 .","journal-title":"N Engl J Med"},{"issue":"3","key":"552_CR104","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1213\/00000539-198803000-00005","volume":"67","author":"EL Maunuksela","year":"1988","unstructured":"Maunuksela EL, Korpela R, Olkkola KT. Comparison of buprenorphine with morphine in the treatment of postoperative pain in children. Anesth Analg. 1988;67(3):233\u20139.","journal-title":"Anesth Analg"},{"issue":"5","key":"552_CR105","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","volume":"9","author":"K Kampman","year":"2015","unstructured":"Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358\u201367. https:\/\/doi.org\/10.1097\/ADM.0000000000000166 .","journal-title":"J Addict Med"},{"issue":"4","key":"552_CR106","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bja\/aer001","volume":"106","author":"F Bressolle","year":"2011","unstructured":"Bressolle F, Khier S, Rochette A, Kinowski JM, Dadure C, Capdevila X. Population pharmacokinetics of nalbuphine after surgery in children. Br J Anaesth. 2011;106(4):558\u201365. https:\/\/doi.org\/10.1093\/bja\/aer001 .","journal-title":"Br J Anaesth"},{"issue":"2","key":"552_CR107","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/clpt.1989.130","volume":"46","author":"P Jaillon","year":"1989","unstructured":"Jaillon P, Gardin ME, Lecocq B, Richard MO, Meignan S, Blondel Y, et al. Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patients. Clin Pharmacol Ther. 1989;46(2):226\u201333.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"552_CR108","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1600-0773.1993.tb01547.x","volume":"73","author":"K Hamunen","year":"1993","unstructured":"Hamunen K, Olkkola KT, Sepp\u00e4l\u00e4 T, Maunuksela EL. Pharmacokinetics and pharmacodynamics of pentazocine in children. Pharmacol Toxicol. 1993;73(2):120\u20133.","journal-title":"Pharmacol Toxicol"},{"issue":"1","key":"552_CR109","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ajhp\/62.1.48","volume":"62","author":"GA Davis","year":"2005","unstructured":"Davis GA, Rudy AC, Archer SM, Wermeling DP. Bioavailability of intranasal butorphanol administered from a single-dose sprayer. Am J Health Syst Pharm. 2005;62(1):48\u201353.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"552_CR110","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/ajhp\/61.3.261","volume":"61","author":"GA Davis","year":"2004","unstructured":"Davis GA, Rudy AC, Archer SM, Wermeling DP. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer. Am J Health Syst Pharm. 2004;61(3):261\u20136.","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"552_CR111","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1460-9592.2005.01738.x","volume":"15","author":"P Bozkurt","year":"2005","unstructured":"Bozkurt P. Use of tramadol in children. Paediatr Anaesth. 2005;15(12):1041\u20137. https:\/\/doi.org\/10.1111\/j.1460-9592.2005.01738.x .","journal-title":"Paediatr Anaesth"},{"issue":"2","key":"552_CR112","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/bja\/aei170","volume":"95","author":"K Allegaert","year":"2005","unstructured":"Allegaert K, Anderson BJ, Verbesselt R, Debeer A, de Hoon J, Devlieger H, et al. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity. Br J Anaesth. 2005;95(2):231\u20139. https:\/\/doi.org\/10.1093\/bja\/aei170 .","journal-title":"Br J Anaesth"},{"issue":"11","key":"552_CR113","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00228-005-0045-3","volume":"61","author":"K Allegaert","year":"2005","unstructured":"Allegaert K, Van den Anker JN, Verbesselt R, de Hoon J, Vanhole C, Tibboel D, et al. O-demethylation of tramadol in the first months of life. Eur J Clin Pharmacol. 2005;61(11):837\u201342. https:\/\/doi.org\/10.1007\/s00228-005-0045-3 .","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"552_CR114","first-page":"109","volume":"49","author":"KA Payne","year":"2002","unstructured":"Payne KA, Roelofse JA, Shipton EA. Pharmacokinetics of oral tramadol drops for postoperative pain relief in children aged 4 to 7\u00a0years\u2013a pilot study. Anesth Prog. 2002;49(4):109\u201312.","journal-title":"Anesth Prog"},{"issue":"9","key":"552_CR115","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1007\/s11095-006-9049-7","volume":"23","author":"MJ Garrido","year":"2006","unstructured":"Garrido MJ, Habre W, Rombout F, Troconiz IF. Population pharmacokinetic\/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics. Pharm Res. 2006;23(9):2014\u201323. https:\/\/doi.org\/10.1007\/s11095-006-9049-7 .","journal-title":"Pharm Res"},{"issue":"3","key":"552_CR116","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cpdd.169","volume":"4","author":"J Vandenbossche","year":"2015","unstructured":"Vandenbossche J, Richards H, Solanki B, Van Peer A. Single- and multiple-dose pharmacokinetic studies of tramadol immediate-release tablets in children and adolescents. Clin Pharmacol Drug Dev. 2015;4(3):184\u201392. https:\/\/doi.org\/10.1002\/cpdd.169 .","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"2","key":"552_CR117","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/bja\/aeh178","volume":"93","author":"J Zwaveling","year":"2004","unstructured":"Zwaveling J, Bubbers S, van Meurs AH, Schoemaker RC, van Heel IR, Vermeij P, et al. Pharmacokinetics of rectal tramadol in postoperative paediatric patients. Br J Anaesth. 2004;93(2):224\u20137. https:\/\/doi.org\/10.1093\/bja\/aeh178 .","journal-title":"Br J Anaesth"},{"key":"552_CR118","unstructured":"United States Food & Drug Administration. FDA Drug Safety Communication. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm549679.htm . Accessed 02 Jan 2019"},{"issue":"3","key":"552_CR119","doi-asserted-by":"publisher","first-page":"e753","DOI":"10.1542\/peds.2014-2673","volume":"135","author":"G Orliaguet","year":"2015","unstructured":"Orliaguet G, Hamza J, Couloigner V, Denoyelle F, Loriot MA, Broly F, et al. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol. Pediatrics. 2015;135(3):e753\u20135. https:\/\/doi.org\/10.1542\/peds.2014-2673 .","journal-title":"Pediatrics"},{"issue":"6","key":"552_CR120","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/pan.13373","volume":"28","author":"M Vittinghoff","year":"2018","unstructured":"Vittinghoff M, L\u00f6nnqvist PA, Mossetti V, Heschl S, Simic D, Colovic V, et al. Postoperative pain management in children: guidance from the pain committee of the European Society for Paediatric Anaesthesiology (ESPA Pain Management Ladder Initiative). Paediatr Anaesth. 2018;28(6):493\u2013506. https:\/\/doi.org\/10.1111\/pan.13373 .","journal-title":"Paediatr Anaesth"},{"issue":"8","key":"552_CR121","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1399-6576.2012.02726.x","volume":"56","author":"S Lundeberg","year":"2012","unstructured":"Lundeberg S, Stephanson N, Stiller CO, Eksborg S. Pharmacokinetics after a single intravenous dose of the opioid ketobemidone in neonates. Acta Anaesthesiol Scand. 2012;56(8):1026\u201331. https:\/\/doi.org\/10.1111\/j.1399-6576.2012.02726.x .","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"552_CR122","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1399-6576.2009.02135.x","volume":"54","author":"S Lundeberg","year":"2010","unstructured":"Lundeberg S, Stephanson N, Lafolie P, Olsson GL, Stiller CO, Eksborg S. Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children. Acta Anaesthesiol Scand. 2010;54(4):435\u201341. https:\/\/doi.org\/10.1111\/j.1399-6576.2009.02135.x .","journal-title":"Acta Anaesthesiol Scand"},{"issue":"8","key":"552_CR123","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/00498250500183181","volume":"35","author":"U Yasar","year":"2005","unstructured":"Yasar U, Annas A, Svensson JO, Lazorova L, Artursson P, Al-Shurbaji A. Ketobemidone is a substrate for cytochrome P4502C9 and 3A4, but not for P-glycoprotein. Xenobiotica. 2005;35(8):785\u201396. https:\/\/doi.org\/10.1080\/00498250500183181 .","journal-title":"Xenobiotica"},{"issue":"4","key":"552_CR124","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00431-005-0021-z","volume":"165","author":"C M\u00fcller","year":"2006","unstructured":"M\u00fcller C, Kremer W, Harlfinger S, Doroshyenko O, Jetter A, Hering F, et al. Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units. Eur J Pediatr. 2006;165(4):229\u201339. https:\/\/doi.org\/10.1007\/s00431-005-0021-z .","journal-title":"Eur J Pediatr"},{"issue":"6","key":"552_CR125","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2125.1980.tb01088.x","volume":"9","author":"TA Moreland","year":"1980","unstructured":"Moreland TA, Brice JE, Walker CH, Parija AC. Naloxone pharmacokinetics in the newborn. Br J Clin Pharmacol. 1980;9(6):609\u201312.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"552_CR126","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/jps.2600601030","volume":"60","author":"SH Weinstein","year":"1971","unstructured":"Weinstein SH, Pfeffer M, Schor JM, Indindoli L, Mintz M. Metabolites of naloxone in human urine. J Pharm Sci. 1971;60(10):1567\u20138.","journal-title":"J Pharm Sci"},{"key":"552_CR127","unstructured":"Kaleo Inc. EVZIO\u2014naloxone hydrochloride injection. https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=5fbe8d17-a72f-406d-a736-48e61620f9d8&type=display . Accessed 02 Jan 2019."},{"issue":"3","key":"552_CR128","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2165\/00003495-198835030-00002","volume":"35","author":"JP Gonzalez","year":"1988","unstructured":"Gonzalez JP, Brogden RN. Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs. 1988;35(3):192\u2013213. https:\/\/doi.org\/10.2165\/00003495-198835030-00002 .","journal-title":"Drugs"},{"issue":"3","key":"552_CR129","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1530-0277.2006.00052.x","volume":"30","author":"JL Dunbar","year":"2006","unstructured":"Dunbar JL, Turncliff RZ, Dong Q, Silverman BL, Ehrich EW, Lasseter KC. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone. Alcohol Clin Exp Res. 2006;30(3):480\u201390. https:\/\/doi.org\/10.1111\/j.1530-0277.2006.00052.x .","journal-title":"Alcohol Clin Exp Res"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-019-00552-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-019-00552-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-019-00552-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:56:14Z","timestamp":1663332974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-019-00552-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":129,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1007\/s13318-019-00552-0","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"22 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"James C. Thigpen declares no conflicts of interest. Brian L. Odle declares no conflicts of interest. Sam Harirforoosh declares no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}